|
|
|
|
LEADER |
03006nam a22003375i 4500 |
001 |
000283841 |
005 |
20210514150850.0 |
007 |
cr nn 008mamaa |
008 |
101109s2011 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781441960825
|
024 |
7 |
|
|a 10.1007/978-1-4419-6082-5
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Molecular Genetics of Liver Neoplasia /
|c edited by Xin Wei Wang, Joe W. Grisham, Snorri S. Thorgeirsson.
|
250 |
|
|
|a 1st ed. 2011.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2011.
|
300 |
|
|
|a XIV, 399 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Cancer Genetics,
|
505 |
0 |
|
|a Part I: Introduction -- 1. Overview of HCC: biology and pathology -- Xin Wei Wang, Joe Grisham and Snorri Thorgeirsson -- 2. Overview of CC: -- Part II: Liver development and pathogenesis -- 3. Embryonic development of the liver -- Kenneth S. Zaret -- 4. Human hepatic cell lineages -- Nelson Fausto -- 5. Pathology of Human Liver Cancer -- Masamichi Kojiro -- Part III: Genetics and epidemiology of liver cancer -- 6. HCC -- Hashem El.Serag -- 7. CC -- Greg Gores -- Part IV: Molecular Basis of Cancer Susceptibility -- 8. Yusuke Nakamura (NCC) -- 9. Hereditary liver diseases with a high risk to develop HCC -- Markus Grompe, [ALSO Marie-Annick Buendia] -- 10. Genetics and epigenetics of preneoplastic liver diaseses and human HCC -- 11. HBV: Jack Wands -- 12. HCV: Stanly Lemon -- 13. Fibrosis and cirrhosis studies -- David Brenner -- 14. Methylation status in chronic liver disease and HCC -- Yae Kanai (Japan) -- Part V. Animal models -- 15. Transgenic mouse models -- Snorri Thorgeirsson & Joe Grisham -- 16. Mosaic mouse model -- Scott Lowe -- 17. Zebrafish model -- Zhiyuan Gong (NUS): -- Part VI: Global gene expression profiling of human liver cancer -- 18. Integrative and functional genomics of HCC -- Snorri Thorgeirsson: -- 19. Molecular signatures of metastatic HCC -- Xin Wei Wang -- 20. Liver cancer heterogeneity and tumor subtypes -- Jessica Rossi -- 21. Gene expression studies in cholangiocarcinoma -- Yoichi Furokawa -- Part VII: Cancer stem cells -- 22. Snorri Thorgeirsson -- 23. Tania Roskams -- Part VIII: Liver cancer genetics in the clinic -- 24. Biomarkers and clinical staging of liver cancer -- Josep Llovet -- 25. Molecular signaling in HCC -- Hong Yang Wang (Shanghai) -- 26. Molecular oncology and HCC -- Zhao-You Tang (Shanghai) -- 27. Molecular pathogenesis of HCC -- Irene Ig (Hong Kong).
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
700 |
1 |
|
|a Wang, Xin Wei.
|e editor.
|
700 |
1 |
|
|a Grisham, Joe W.
|e editor.
|
700 |
1 |
|
|a Thorgeirsson, Snorri S.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|